MedPath

Flaximed

Brand Name: Flaximed

Generic Name: Cefalexin (as monohydrate)

Active
Registration Number

DRP-1426-12

Dosage Form

Powder For Suspension

Issuance Date

February 2, 2022

Expiry Date

February 5, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg/5 mL
PackagingN/A

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
ANTIBACTERIAL (CEPHALOSPORIN)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefalexin (as monohydrate)Active
Monograph: cefalexin (as monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform